Clearmind Medicine Inc (NASDAQ: CMND) has announced the filing of a provisional patent application for the treatment of Dyskinesia with the United States Patent and Trademark Office (USPTO) as part of its overarching strategy to strengthen its IP portfolio further. What Happened: The patent application refers to the psychedelic molecule 3-Methylmethcathinone (3-MMC) as a potential treatment for Dyskinesia and expands Clearmind's portfolio for innovative molecules, new indications, and treatments
Boletín de Luchas Obreras de 26 de julio de 2021 kaosenlared.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kaosenlared.net Daily Mail and Mail on Sunday newspapers.
Share:
EV news just keep on coming.
Hyundai Motor Company (OTC: HYMTF) confirmed several new models in an investor presentation. But, in the EV world where software is more important than hardware, equipment makers are just as important as automakers, with a few players even promising to bring the game to a whole new level or change the rules entirely beside well-known companies like
Tesla (NASDAQ: TSLA) or
General Motors (NYSE: GM). One such player is
Worksport Ltd (OTC: WKSP) which has partnered with Atlis Motor Vehicles and Hercules Electric Vehicles to configure its revolutionary solar fusion technology TerraVis for their upcoming electric pickups. The company has just issued a progress update this morning to its investors, shareholders, and supporters about how it continues to expand its customer base.